Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
about
Mouse models of ciliopathies: the state of the art.Obesity-associated hepatosteatosis and impairment of glucose homeostasis are attenuated by haptoglobin deficiency.Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitisMelanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis.NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.Experimental models of liver fibrosisCathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptorHigh maysin corn silk extract reduces body weight and fat deposition in C57BL/6J mice fed high-fat diets.Modes-of-Action Related to Repeated Dose Toxicity: Tissue-Specific Biological Roles of PPAR γ Ligand-Dependent Dysregulation in Nonalcoholic Fatty Liver Disease.Endoplasmic reticulum stress does not contribute to steatohepatitis in obese and insulin-resistant high-fat-diet-fed foz/foz mice.Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis.Surgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity.Beyond reasonable doubt: who is the culprit in lipotoxicity in NAFLD/NASH?Attenuation of fatty liver and prevention of hypercholesterolemia by extract of Curcuma longa through regulating the expression of CYP7A1, LDL-receptor, HO-1, and HMG-CoA reductase.Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation.Alström syndrome: genetics and clinical overviewStrain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype.Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis.Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.Obeticholic acid improves adipose morphometry and inflammation and reduces steatosis in dietary but not metabolic obesity in mice.A truncating mutation of Alms1 reduces the number of hypothalamic neuronal cilia in obese mice.Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.Causes and mechanisms of adipocyte enlargement and adipose expansion.Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.Exercise improves adipose function and inflammation and ameliorates fatty liver disease in obese diabetic mice
P2860
Q27692039-15604033-6902-45A5-B352-505C1E2CFDAFQ35227192-B5906E96-F0A9-4E2C-BF25-03959247E282Q35268966-3BE8678A-20A7-4E3E-AC10-EDA2D6DF61C8Q35474335-10ABD556-3168-4C08-845D-BC068E37EFEEQ35931190-9BBE30FE-6B23-46FE-B12C-BEDA9ED09EB1Q36442525-30165044-A792-4655-B962-35293A900658Q37239135-9C9D7BA7-6062-4B7A-A3D4-AE737504189BQ37448467-8FE015C5-54C7-4911-9E73-2DBCBBB5A722Q38207591-5B3CF7B4-CC43-440B-9CDD-3CD4709930BDQ38307548-C422B628-E23E-46EC-8685-179DAD57ACDBQ38802973-ACF92561-D0F4-4422-A3C2-A051261A16B4Q40015708-316A30AE-CFE6-4349-A90B-E6AEEEE3A66AQ41278014-197404C1-9276-4CC0-8696-B681A9D6BE63Q42741133-C43054D7-B927-462E-A06B-B820ED14A080Q42806308-E22F6E58-31C6-443D-AA1D-A636D1AA6ADBQ42813081-45060C16-91E0-498E-A89A-7EC3DEE36BACQ44675090-FFFCA2B3-7120-48E2-B98F-0ED06CDE0601Q44993268-C4EDFAE1-2439-440C-8F85-E17F341C1479Q45345979-F9AAF783-7600-4DA1-8104-618B8A0E3FF7Q47958825-2382B44F-A757-4902-BFCF-F2F776D2C700Q48515414-6B674FD5-DC58-4482-BFC2-E8EEC5D3AEEDQ48606073-B7639BB3-6FEA-4F51-A81E-DF19B682E17CQ49832016-D9282B35-5E0F-4B51-8311-02F195D13790Q51412091-8FB00119-ACC0-41BA-BA0C-E11CEDF79DFFQ58316278-21266852-01A6-4C6A-8630-A9B8487A51B6
P2860
Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Roles of adipose restriction a ...... titis in obese, diabetic mice.
@en
Roles of adipose restriction a ...... titis in obese, diabetic mice.
@nl
type
label
Roles of adipose restriction a ...... titis in obese, diabetic mice.
@en
Roles of adipose restriction a ...... titis in obese, diabetic mice.
@nl
prefLabel
Roles of adipose restriction a ...... titis in obese, diabetic mice.
@en
Roles of adipose restriction a ...... titis in obese, diabetic mice.
@nl
P2093
P2860
P1476
Roles of adipose restriction a ...... titis in obese, diabetic mice.
@en
P2093
Claire Z Larter
Derrick M Van Rooyen
Geoffrey C Farrell
Jacqueline Williams
Jing Yun Hou
John Brooling
Matthew Clyne
Matthew M Yeh
Narci C Teoh
P2860
P304
P356
10.1111/J.1440-1746.2009.05996.X
P577
2009-10-01T00:00:00Z